Knowles Corporation · NYSE:KN
Knowles — Q1 2026 Earnings Presentation
15 slides from Knowles's earnings presentation, Apr 23, 2026
Slide 1: 1st Quarter 2026 Earnings Release Supplemental Information
04.23.26 1st Quarter 2026 Earnings Release Supplemental Information
Slide 2: Safe Harbor: Forward Looking Statements
Safe Harbor Forward Looking Statements A number of statements in our presentations, the accompanying slides, and the responses to questions on our conference call discussing our quarterly results may constitute forward-looking statements within the meaning of the safe harbor provisions of the United
Slide 3: First Quarter Results
First Quarter Results Revenue Non-GAAP Diluted EPS* Net Cash (Used in) Revenues grew 15.8% driven ($) Provided by by increased demand for our ($M) Operating Activities products and new design ($M) win strength in both the Precision Devices and MedTech and Specialty Audio segments. Non-GAAP Diluted E
Slide 4: MedTech & Specialty Audio
SEGMENT PERFORMANCE MedTech & Specialty Audio Revenue Adjusted EBITDA Margin* ($) (%) First quarter revenue growth was driven by increased hearing health shipments associated with our customers' successful new product introductions coupled with our position on these platforms. +13.9% +480 bps Adjust
Slide 5: Precision Devices
SEGMENT PERFORMANCE Precision Devices Revenue Adjusted EBITDA Margin* ($) (%) Revenue grew 17.4% in the first quarter driven by broad based strength across all of our end markets. Adjusted EBITDA margins increased, driven by pricing +17.4% +260 and higher end market bps demand increasing factory cap
Slide 6: Second Quarter 2026 Outlook
Second Quarter 2026 Outlook GAAP Adjustments Non-GAAP Revenues from continuing operations $152 to $162 million $— $152 to $162 million Diluted earnings per share from $0.18 to $0.22 $0.10 $0.28 to $0.32 continuing operations Net cash provided by operating activities $20 to $30 million $— $20 to $30
Slide 7: Appendix
« knowles Appendix
Slide 8: Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures
RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES Quarter Ended March 31, (continuing operations, in millions, except per share amounts) 2026 2025 Revenues $ 153.1 $ 132.2 Notes Gross profit $ 67.1 $ 53.3 1. Production transfer costs represent duplicate costs incurred to migra
Slide 9: Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures
RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES Quarter Ended March 31, (continuing operations, in millions, except per share amounts) 2026 2025 Notes Net earnings (loss) $ 11.3 $ (0.4) 5. The non-GAAP reconciling adjustments include stock-based compensation expense, Interes
Slide 10: Historical Segment Data
HISTORICAL SEGMENT DATA PRECISION DEVICES MEDTECH & SPECIALTY AUDIO Quarter Ended Quarter Ended March 31, December 31, September 30, June 30, March 31, March 31, December 31, September 30, June 30, March 31, (continuing operations, in millions) 2026 2025 2025 2025 2025 2026 2025 2025 2025 2025 Reven
Slide 11: Historical Segment Data
HISTORICAL SEGMENT DATA PRECISION DEVICES MEDTECH & SPECIALTY AUDIO Quarter Ended Quarter Ended March 31, December 31, September 30, June 30, March 31, March 31, December 31, September 30, June 30, March 31, (continuing operations, in millions) 2026 2025 2025 2025 2025 2026 2025 2025 2025 2025 Reven
Slide 12: Reconciliation of Net Earnings to Adjusted EBITDA
RECONCILIATION OF NET EARNINGS TO ADJUSTED EBITDA Quarter Ended March 31, December 31, September 30, June 30, Trailing (continuing operations, in millions) 2026 2025 2025 2025 12-months Net earnings $ 11.3 $ 25.5 $ 18.0 $ 7.8 $ 62.6 Interest expense, net 1.5 1.8 2.3 2.5 8.1 (Benefit from) provision
Slide 13: Reconciliation of Net Debt
RECONCILIATION OF NET DEBT (in millions) March 31, 2026 Current maturities of long-term debt $ — Long-term debt 131.0 Total debt 131.0 Less: Cash and cash equivalents (41.0) Net debt $ 90.0 Net debt $ 90.0 Trailing 12 Month Adjusted EBITDA $ 148.8 Net debt leverage ratio 0.6 x 13
Slide 14: Cash Generated by Operating Activities of Continuing Operations
CASH GENERATED BY OPERATING ACTIVITIES OF CONTINUING OPERATIONS Quarter Ended March 31, December 31, March 31, 2026 2025 2025 Revenues $ 153.1 $ 162.2 $ 132.2 Net cash (used in) provided by operating activities (0.7) 47.2 1.3 Amounts utilized by discontinued operations 8.4 1.3 21.0 Non-GAAP net cash
Slide 15: Thank you.
Thank you. « knowles